Indian Firm Panacea Says Aiming to Make Covid-19 Vaccine

Indian Firm Panacea Says Aiming to Make Covid-19 Vaccine

FILE PHOTO: Small bottles labeled with a

FILE PHOTO: Small bottles labeled with a “Vaccine COVID-19” sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. REUTERS/Dado Ruvic/Illustration

The collaboration aims to make more than 500 million doses of the vaccine candidate, with over 40 million doses expected to be available early next year, Panacea said in a statement to stock exchanges.

  • Reuters Bengaluru
  • Last Updated: June 10, 2020, 11:15 AM IST

Indian biotech firm Panacea Biotec Ltd said on Wednesday it would partner with US-based Refana Inc to make a potential vaccine for Covid-19.

The collaboration aims to make more than 500 million doses of the vaccine candidate, with over 40 million doses expected to be available early next year, Panacea said in a statement to stock exchanges.

Panacea’s shares jumped 20 per cent in morning trading on India’s National Stock Exchange after the news.



https://pubstack.nw18.com/pubsync/fallback/api/videos/recommended?source=n18english&channels=5d95e6c378c2f2492e2148a2&categories=5d95e6d7340a9e4981b2e10a&query=Indian,Firm,Panacea,Says,Aiming,to,Make,Covid-19,Vaccine,coronavirus,indian,&publish_min=2020-06-08T15:01:18.000Z&publish_max=2020-06-10T15:01:18.000Z&sort_by=date-relevance&order_by=0&limit=2

Next Story

editor

Leave a Reply

Your email address will not be published. Required fields are marked *